Activation of TRPV4 Increases Neovascularization of Rat Prefabricated Flaps
04 April 2017
20 July 2017
18 September 2017 (eFirst)
Background Inadequate neovascularization is a major risk factor that can lead to subsequent necrosis of prefabricated flaps. Recent evidence indicates that transient receptor potential cation channel, subfamily V, member 4 (TRPV4) activates growth and remodeling of collateral arteries in ischemia tissues by responding to elevated fluid shear stress (FSS). Therefore, we evaluated whether TRPV4 could increase neovascularization in prefabricated flaps in a rat model.
Methods Rat prefabricated skin flaps were created by ligating the right femoral vascular pedicle and implanting it underneath abdominal flaps. Thirty-six male Sprague–Dawley rats were randomly assigned to three groups with different solutions injected subcutaneously in the implantation site around the pedicle: injected with normal saline as the control group; injected with 4α-Phorbol 12,13-didecanoate (4αPDD), a specific TRPV4 activator, as the 4αPDD group; or injected with ruthenium red (RR), a TRPV-blocker, as the RR group. Neovascularization was evaluated by laser speckle contrast imaging (FLPI), histological staining, and enzyme-linked immunosorbent assay (ELISA) within two weeks. Afterwards, the abdominal island flaps were completely elevated and sutured back. The flap viability and survival area were examined on day 7.
Results A larger area of flap survival, higher capillary densities, and higher von Willebrand factor (vWF) expression were observed in the 4αPDD group in comparison to those in the other two groups. The secretion of vascular endothelial growth factor (VEGF), but not basic fibroblast growth factor (bFGF), was significantly elevated in the 4αPDD group.
Conclusion Activation of TRPV4 using 4αPDD can significantly increase the survival of prefabricated flaps via neovascularization inducement, possibly through VEGF secretion enhancement. TRPV4 serves as a potential therapeutic neovascularization target in prefabricated flaps.
* These authors contributed equally to this work.
- 1 Li Q, Zan T, Li H. , et al. Flap prefabrication and stem cell-assisted tissue expansion: how we acquire a monoblock flap for full face resurfacing. J Craniofac Surg 2014; 25 (01) 21-25
- 2 Li Q, Zan T, Gu B. , et al. Face resurfacing using a cervicothoracic skin flap prefabricated by lateral thigh fascial flap and tissue expander. Microsurgery 2009; 29 (07) 515-523
- 3 Xu H, Feng S, Xia Y. , et al. Prefabricated flaps: identification of microcirculation structure and supercharging technique improving survival area. J Reconstr Microsurg 2017; 33 (02) 112-117
- 4 Gurunluoglu R, Meirer R, Shafighi M, Huemer GM, Yilmaz B, Piza-Katzer H. Gene therapy with adenovirus-mediated VEGF enhances skin flap prefabrication. Microsurgery 2005; 25 (05) 433-441
- 5 Fang T, Lineaweaver WC, Chen MB, Kisner C, Zhang F. Effects of vascular endothelial growth factor on survival of surgical flaps: a review of experimental studies. J Reconstr Microsurg 2014; 30 (01) 1-13
- 6 Du Z, Zan T, Li H, Li Q. A study of blood flow dynamics in flap delay using the full-field laser perfusion imager. Microvasc Res 2011; 82 (03) 284-290
- 7 Zan T, Li Q, Dong J. , et al. Transplanted endothelial progenitor cells increase neo-vascularisation of rat pre-fabricated flaps. J Plast Reconstr Aesthet Surg 2010; 63 (03) 474-481
- 8 Xu H, Zhang Z, Tao W. , et al. Ex vivo delay: a novel approach to increase prefabricated flaps survival rate. J Reconstr Microsurg 2016; 32 (08) 632-638
- 9 Schierling W, Troidl K, Apfelbeck H. , et al. Cerebral arteriogenesis is enhanced by pharmacological as well as fluid-shear-stress activation of the Trpv4 calcium channel. Eur J Vasc Endovasc Surg 2011; 41 (05) 589-596
- 10 Troidl C, Troidl K, Schierling W. , et al. Trpv4 induces collateral vessel growth during regeneration of the arterial circulation. J Cell Mol Med 2009; 13 (8B, 8b): 2613-2621
- 11 Zan T, Li H, Du Z. , et al. Reconstruction of the face and neck with different types of pre-expanded anterior chest flaps: a comprehensive strategy for multiple techniques. J Plast Reconstr Aesthet Surg 2013; 66 (08) 1074-1081
- 12 Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011; 473 (7347): 298-307
- 13 Galie PA, Nguyen D-HT, Choi CK, Cohen DM, Janmey PA, Chen CS. Fluid shear stress threshold regulates angiogenic sprouting. Proc Natl Acad Sci U S A 2014; 111 (22) 7968-7973
- 14 Yin J, Kuebler WM. Mechanotransduction by TRP channels: general concepts and specific role in the vasculature. Cell Biochem Biophys 2010; 56 (01) 1-18
- 15 Sonkusare SK, Bonev AD, Ledoux J. , et al. Elementary Ca2+ signals through endothelial TRPV4 channels regulate vascular function. Science 2012; 336 (6081): 597-601
- 16 Hirase T, Node K. Endothelial dysfunction as a cellular mechanism for vascular failure. Am J Physiol Heart Circ Physiol 2012; 302 (03) H499-H505
- 17 Xu H, Zhang Z, Xia Y. , et al. Preliminary exploration: when angiosome meets prefabricated flaps. J Reconstr Microsurg 2016; 32 (09) 683-687
- 18 Troidl C, Nef H, Voss S. , et al. Calcium-dependent signalling is essential during collateral growth in the pig hind limb-ischemia model. J Mol Cell Cardiol 2010; 49 (01) 142-151
- 19 Thoppil RJ, Cappelli HC, Adapala RK, Kanugula AK, Paruchuri S, Thodeti CK. TRPV4 channels regulate tumor angiogenesis via modulation of Rho/Rho kinase pathway. Oncotarget 2016; 7 (18) 25849-25861
- 20 Cordeiro S, Seyler S, Stindl J, Milenkovic VM, Strauss O. Heat-sensitive TRPV channels in retinal pigment epithelial cells: regulation of VEGF-A secretion. Invest Ophthalmol Vis Sci 2010; 51 (11) 6001-6008